The clinical pharmacy team can provide in-service education about such situations and guide the healthcare team in conducting proper medication histories and making necessary adjustments
The appropriate choice depends on individual factors including: Medical Eligibility: Determined by a licensed clinician based on health history, BMI, and contraindications Regulatory Framework: FDA-approved finished products versus compounded formulations prepared under current federal and state regulations Financial Considerations: Insurance coverage availability, manufacturer programs, or cash-pay options through telehealth platforms Personal Preferences: Comfort level with different regulatory frameworks, access methods, and monitoring approaches Only you and your healthcare provider can determine what pathway, if any, is appropriate for your situation
Comparative Mechanisms with Other Agents Compared with metformin, which improves insulin sensitivity primarily through hepatic and muscular pathways, GLP-1 RAs act centrally and peripherally to influence appetite, glucose metabolism, and systemic inflammation
Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug on March 31, offering eligible self-pay patients lower monthly prices on both the injection and pill versions of the product
We aimed to assess the relationship between GLP-1s and osteoporosis likelihood across different amounts of weight change among patients with and without diabetes
Mounjaro treats type 2 diabetes, while Zepbound helps with weight loss